AnalystsMichael FreemanMichael Freeman's Stock Forecasts
AnalystsMichael Freeman
Sectors:
Analyst Ranking
Top 42%
#2089 out of 4986 analysts
Average Return
+13.82%
Win Rate
80%4 out of 5
Risk vs Reward
Poor
Good
Michael Freeman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avidity Biosciences IncRNA | +37.52% | $32.01 | $44.02 | 2025-06-10 - 2025-08-19 | Strong Buy |
Wave Life Sciences LtdWVE | +32.27% | $7.19 | $9.51 | 2025-06-10 - 2025-08-19 | Buy |
Disc Medicine IncIRON | +14.39% | $50.86 | $58.18 | 2025-06-10 - 2025-08-19 | Strong Buy |
Tectonic Therapeutic IncTECX | +0.85% | $23.50 | $23.70 | 2025-06-10 - 2025-08-19 | Buy |
Michael Freeman Analyst Color
Get additional color on Michael Freeman's coverage of popular stocks
Michael Freeman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Wave Life Sciences LtdWVE | 1 | Buy | $14.00 | +47.21% | Assumes | 2 months ago |
Tectonic Therapeutic IncTECX | 1 | Buy | $76.00 | +220.68% | Reinstates | 2 months ago |
Dyne Therapeutics IncDYN | 1 | Buy | $37.00 | +202.04% | Assumes | 2 months ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | +52.97% | Reinstates | 2 months ago |
Avidity Biosciences IncRNA | 1 | Strong Buy | $65.00 | +47.66% | Initiates Coverage On | 2 months ago |
Bausch Health Companies IncBHC | 1 | Hold | $8.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.